Tick (check) box to add article to PDF "basket"
Marine fungi such as those growing on algae and corals generate powerful substances that could be used to target tumours. An EU-funded project has identified three particularly promising compounds and developed ways to produce them on an industrial scale - without damage to the fungi's natural habitat.
Published: 5 February 2016
A portable device to detect potential signs of cancer in a patient's urine is under development within the EU-funded research project GLAM. The project aims to speed up cancer diagnosis and monitoring, while making the process both less intrusive and less unpleasant.
Published: 4 February 2016
EU-funded researchers are advancing a novel form of cancer therapy described as a 'magic bullet' against certain types of tumours. Their work promises to lead to more personalised and effective treatments for breast, ovarian and other forms of cancer over the coming years.
Published: 27 November 2015
Chemotherapy can have a considerable impact on patients' quality of life, causing nausea or hair loss as well as depression and anxiety. More personalised care could help many patients and even improve outcomes. The EU-funded project eSMART is putting a mobile phone-based remote patient monitoring system to the test.
Published: 17 November 2015
Breast cancer is the leading cause of cancer deaths in women, with more than one million cases diagnosed in the world every year. The EU-funded BASIS project has reached a major milestone in characterising the different genetic mutations that lie behind this disease - defining the range of possibilities for drug development.
Published: 1 October 2015
An international team of researchers, led by ERC grantee Prof Rune Linding, discovered how genetic cancer mutations attack the networks controlling human cells. This knowledge is critical for the future development of personalized precision cancer treatments.
Published: 1 October 2015
Human papillomavirus has long been associated with the vast majority of cervical and anogenital cancers diagnosed worldwide, but its role in head-and-neck cancers has been less widely researched. In a landmark case study, EU-funded researchers are characterising the connection in order to advance the development of new screening and diagnostic techniques.
Published: 2 September 2015
EU-funded researchers have developed an innovative new cancer treatment. Interest from the pharmaceutical industry has been so great that the research team has set up a company dedicated to bringing their innovations to market.
Published: 1 September 2015
Researchers are blazing a trail towards personalised medicine in cancer care. This will mean the provision of new immunotherapy treatments targeting some of the most complicated conditions. In line with this approach an EU-funded project is developing new technologies to help doctors provide targeted, individual treatments. It has so far conducted clinical trials involving eight melanoma patients to demonstrate the potential of this approach.
Published: 18 August 2015
An EU-funded project is attempting to validate a prototype test designed to predict which combination therapy would best suit individual patients with colorectal cancer, the most common form of cancer in Europe. The test is expected to lengthen the life expectancy for those with this aggressive form of cancer by indicating the most effective treatment combination for individual patients.
Published: 13 August 2015